Loading…
Maxposure (MAXPOSURE)₹29.80−9.42%Media & Entertainment
In the Mar 2026 quarter (consolidated), Maxposure reported sales of ₹42.38 Cr, up 32.1% from Mar 2025, and net profit of ₹4.37 Cr, up 25.9% year on year. For the year to Mar 2026, sales were ₹87.67 Cr and net profit ₹9.47 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 27.03 | 31.00 | 32.08 | 45.29 | 42.38 |
| Expenses | 22.40 | 24.65 | 27.79 | 38.71 | 36.14 |
| Operating Profit | 4.65 | 6.36 | 4.35 | 6.63 | 6.31 |
| OPM % | 17.1% | 20.5% | 13.5% | 14.6% | 14.8% |
| Other Income | 0.51 | 0.76 | 0.57 | 0.18 | 0.54 |
| Interest | 0.22 | 0.05 | 0.25 | 0.39 | 0.58 |
| Depreciation | 0.28 | 0.36 | 0.40 | 0.43 | 0.46 |
| Profit before tax | 4.65 | 6.70 | 4.28 | 5.99 | 5.80 |
| Tax % | 2.4% | 25.1% | 18.9% | 15.2% | 24.5% |
| Net Profit | 4.54 | 5.02 | 3.47 | 5.08 | 4.37 |
| EPS (Rs) | 2.01 | 2.22 | 1.54 | 2.25 | 1.94 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales | 47.13 | 63.02 | 87.67 |
| Expenses | 36.46 | 52.45 | 74.87 |
| Operating Profit | 10.70 | 10.69 | 12.95 |
| OPM % | 22.7% | 16.9% | 14.7% |
| Other Income | 1.74 | 1.34 | 0.73 |
| Interest | 0.51 | 0.30 | 0.98 |
| Depreciation | 0.53 | 0.77 | 0.90 |
| Profit before tax | 11.41 | 10.99 | 11.80 |
| Tax % | 29.2% | 22.7% | 19.8% |
| Exceptional items | 0.67 | 0.00 | 0.00 |
| Net Profit | 8.09 | 8.48 | 9.47 |
| EPS (Rs) | 3.58 | 3.75 | 4.18 |
| Dividend payout % | 0.0% | 0.0% | 0.0% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 22.76 | 22.76 | 22.76 |
| Reserves | 33.94 | 52.83 | 56.42 |
| Borrowings | 1.47 | 8.02 | 10.50 |
| Other Liabilities | 16.20 | 16.30 | 14.37 |
| Total Liabilities | 74.37 | 99.91 | 104 |
| Fixed Assets | 4.02 | 18.25 | 19.62 |
| CWIP | 0.00 | 0.33 | 0.00 |
| Investments | 26.40 | 26.39 | 26.40 |
| Other Assets | 43.95 | 54.94 | 58.03 |
| Inventories | 0.42 | 0.39 | 1.07 |
| Trade receivables | 19.93 | 23.83 | 25.29 |
| Cash & equivalents | 19.37 | 14.79 | 13.74 |
| Total Assets | 74.37 | 99.91 | 104 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from operating activity | 0.28 | −17.15 | −2.53 |
| Cash from investing activity | 1.44 | −4.03 | −0.27 |
| Cash from financing activity | 14.90 | 16.61 | 1.76 |
| Net cash flow | 16.55 | −4.58 | −1.04 |
| Capex | 1.95 | 1.33 | 1.02 |
| Free cash flow | −1.68 | −18.41 | −3.54 |
| CFO / OP % | 3.0% | −160.0% | −19.0% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor days | 154 | 138 | 106 |
| Cash conversion cycle | 153 | 137 | 105 |
| Working capital days | 49 | 49 | 60 |
| ROCE % | — | 16.4% | 15.3% |
For the Mar 2026 quarter, Maxposure reported sales of ₹42.38 Cr, up 32.1% year on year and net profit of ₹4.37 Cr, up 25.9% year on year. The operating margin was 14.8%.
Maxposure's sales for the year to Mar 2026 were ₹87.67 Cr.
Net profit for the year to Mar 2026 was ₹9.47 Cr. Earnings per share over the same trailing period were ₹4.18.
Maxposure reported borrowings of ₹10.50 Cr at Mar 2026, against cash and equivalents of ₹13.74 Cr.
Cash from operations was −₹2.53 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹3.54 Cr.